David Byram
General Counsel chez BRAEBURN INC.
Profil
David Byram is currently working as the VP-Market Access & State Government Affairs at Braeburn Pharmaceuticals SPRL and Braeburn, Inc. He has previously worked as the Senior Vice President-Commercial Affairs at Orexo AB and as the Chief Commercial Officer at StageZero Life Sciences Ltd.
Mr. Byram completed his undergraduate degree from Indiana University.
Postes actifs de David Byram
| Sociétés | Poste | Début |
|---|---|---|
| BRAEBURN INC. | General Counsel | - |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | General Counsel | - |
Anciens postes connus de David Byram
| Sociétés | Poste | Fin |
|---|---|---|
| OREXO AB | Corporate Officer/Principal | - |
| STAGEZERO LIFE SCIENCES LTD. | Corporate Officer/Principal | - |
Formation de David Byram
| Indiana University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| OREXO AB | Health Technology |
| STAGEZERO LIFE SCIENCES LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Braeburn Pharmaceuticals SPRL
Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Health Technology |
Braeburn, Inc.
 Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
